Pharmacists in Russellville, Arkansas


45 Pharmacists found in Russellville
female pharmacist

Qinmi Amy Wang, PHARMACIST


Pharmacist
2109 W Main St, Russellville, AR 72801
479-498-9540    

male pharmacist

Randy Paul Stayton


Pharmacist
2109 W Main, Russellville, AR 72801
479-498-9540     479-498-9543

male pharmacist

Roy Dean Walker, PD


Pharmacist
121 N Commerce Ave, Russellville, AR 72801
479-968-2456     479-968-7914



female pharmacist

Ryan Higgs


Pharmacist
2409 E Main St, Russellville, AR 72802
479-968-2970    

female pharmacist

Dr. Sarah Mccoy, PHARMD


Pharmacist
1100 E Main St, Russellville, AR 72801
479-967-1573     479-967-1594

female pharmacist

Savannah Mcknight


Pharmacist
2409 E Main St, Russellville, AR 72802
479-968-2970    

female pharmacist

Shakeena Johnson, PHARMD


Pharmacist
2409 E Main St, Russellville, AR 72802
479-968-2970    

female pharmacist

Stacy Wilkins, PHARMD


Pharmacist
715 W Main St, Russellville, AR 72801
479-968-1157    

female pharmacist

Susan F Newton, PD


Pharmacist
1808 W Main St, Russellville, AR 72801
479-964-9272     479-964-9280

male pharmacist

Thomas Matthew Wilkins


Pharmacist
2109 W Main St, Russellville, AR 72801
479-498-9540    

male pharmacist

Dr. William John Cobb, PHARMD


Pharmacist
108 Skyline Dr Ste B, Russellville, AR 72801
479-968-7180     479-967-0884

male pharmacist

William Newton Ii


Pharmacist
715 W Main St, Russellville, AR 72801
479-968-1157    

female pharmacist

Dr. Yanci Leigh Walker, PHARM.D.


Pharmacist
121 N Commerce Ave, Russellville, AR 72801
479-968-2456     479-968-7914


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.